Methods and compositions useful for promoting sleep in animals
A technology of animal sleep and composition, applied in the directions of drug combination, botanical equipment and method, animal repellent, etc., can solve problems such as unclear
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0065] After collecting baseline data for all animals, 48 dogs at least 9 years old were divided into treatment and control groups. Each group included 24 animals. The animals were fed either: (1) a control diet containing 28% crude protein, 12% crude fat, 3% crude fiber, and 181 ppm zinc, or (2) a treatment diet containing 28% crude protein, 12% crude fat and 3% crude fiber and 13.5ppm melatonin, 8.2ppm astaxanthin and 208ppm zinc. The amount of melatonin is based on a dose of about 0.1 mg / kg / bw.
[0066] Animals were given control or treatment chow for 77 days. All animals were fed twice a day at 9AM (±30 minutes) and 6PM (±30 minutes). Animals in the treatment group were fed control chow at breakfast and treatment chow at afternoon meal. Animals assigned to the control group were fed twice a day at 9 AM (±30 minutes) and 6 PM (±30 minutes), respectively, and were fed control chow in both AM and PM.
Embodiment 2
[0068] Using a crossover design, all animals were given either a control placebo or a therapeutic supplement containing melatonin. The animals are senior animals (senior animals), and the age of the dogs is more than 10 years. There were 4 males and 4 females in each group. During the intervention phases (Phase 2 and 4), all animals were given melatonin either AM or PM. During the control and crossover phases (phases 1 and 3, respectively), animals were given placebo containing methylcellulose contained in gel capsules in the AM or PM, as appropriate.
[0069] Each phase lasts 35 days. Starting from the 29th day of each stage, the animals' autonomous behavior activities were monitored for 4 consecutive days.
[0070] The placebo consisted of a carrier (methylcellulose) contained in a gel capsule, which was administered during the control phase (phases 1 and 3) at AM or PM feeding, with supplementation as appropriate during the next intervention phase. For example, a placeb...
Embodiment 3
[0076] After collecting baseline data for all animals, 48 dogs at least 9 years old were divided into treatment and control groups. Each group included 24 animals. Animals were fed either: (1) a control diet containing 26% crude protein, 16% crude fat, and 3% crude fiber, or (2) a treatment diet containing 26% crude protein, 16% crude Fat and 3% crude fiber and 130ppm melatonin. The amount of melatonin was based on a dose of 0.1 mg / kg / bw. Animals were given control or treatment chow for 77 days. All animals were fed twice a day at 9AM (±30 minutes) and 6PM (±30 minutes). Animals in the control and treatment groups differed only in whether they were supplemented with placebo or melatonin.
[0077] Process and data logging
[0078] A. Activity record
[0079] Using the Actiwatch method ( Activity Monitoring System, Respironics Co., Inc., Bend, OR), for 5 consecutive days and 5 nights for Example 1 and 3 consecutive days and 4 nights for Example 2, to evaluate 24-hou...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com